Figure 5.
Distribution of inpatient cost per day (A) and total cost (B) for patients who received an allogeneic transplant (n = 375), with TA-TMA vs without TA-TMA. (A) With TA-TMA (n = 137) vs those without TA-TMA (n = 238), cost per day from day 15 to day 365 after HCT (P = .988). (B) With TA-TMA (n = 137) vs those without TA-TMA (n = 238): total cost (P < .001).